Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FU204
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,947
Award facts
- Contract value 100% obligated
- $3,946.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,946.63 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count packages) on November 26, 2025, with a completion date of November 28, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical distributor supporting federal medical procurement across military and veteran healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen leverages its comprehensive IDC with DLA to supply a broad portfolio of medications and medical supplies, including brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic domains. This particular delivery order for Contrave, a prescription weight-management medication, exemplifies the company's role in fulfilling targeted pharmaceutical needs within the Defense Health Agency and broader military healthcare infrastructure. The award reflects AmerisourceBergen's established capacity to execute time-sensitive medical supply deliveries through the DLA's streamlined delivery order mechanism, ensuring consistent pharmaceutical availability for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FU204?
SPE2DR26FU204 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FU204 worth?
The government has obligated $3,947 on SPE2DR26FU204.
Is contract SPE2DR26FU204 an order under another contract?
Yes. SPE2DR26FU204 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU204 competed?
The extent of competition for SPE2DR26FU204 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award